Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Rabies: Still a silent killer targeting the poor

Henry Wilde1, Siriporn Ghai1, Thiravat Hemachudha1

  • 1WHO Collaborating Centre for Research and Training on Viral Zoonoses, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.

Vaccine
|March 28, 2017
PubMed
Summary

No abstract available in PubMed .

Keywords:
Access to rabies post exposure prophylaxis in developing countriesHuman rabies deathsPost exposure prophylaxis

Related Experiment Videos

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

6.5K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.5K
Rab Proteins01:14

Rab Proteins

5.3K
Rab proteins constitute the largest family of monomeric GTPases, of which 70 members are present in humans. Rab proteins and their effectors regulate consecutive stages of vesicle transport such as vesicle transport, docking, and fusion to the correct recipient membrane.
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
5.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reply to Willoughby on the Demise of the Milwaukee Protocol for Rabies.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2025
Same author

Understanding the genetics and neurology: an overview of adult neurogenetics.

Asian biomedicine : research, reviews and news·2025
Same author

Comparison of intravenous immunoglobulin and plasma exchange in hospital-acquired infections of autoimmune encephalitis in a tertiary care center.

Asian biomedicine : research, reviews and news·2025
Same author

Antibodies response in symptomatic and asymptomatic SARS-CoV-2 infected persons in Thailand.

PloS one·2025
Same author

The Bayesian approach for real-world implementation of plasma p-tau217 in tertiary care memory clinics in Thailand.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2024
Same author

The first human case report of molecularly confirmed co-infection of <i>Brucella melitensis</i> and <i>Coxiella burnetii:</i> A case report.

Heliyon·2024
Same journal

Adverse events and vaccine administration errors following RSV vaccination: Findings from the United States VAERS database, 2023-2025.

Vaccine·2026
Same journal

Protocol for a phase 3, randomized, double-blind clinical trial evaluating the safety and immunogenicity of the MVA-BN® vaccine against mpox in children aged 4 to less than 24 months in the Democratic Republic of the Congo: Data to guide future paediatric vaccination strategies.

Vaccine·2026
Same journal

Human systemic and mucosal immune responses support further exploration of a Klebsiella pneumoniae protein-based vaccine.

Vaccine·2026
Same journal

Corrigendum to "Immunogenicity and safety of a quadrivalent recombinant influenza vaccine manufactured in Iran (FluGuard) in volunteers aged 18-60 years: A double-blind, non-inferiority, randomized controlled trial" [Vaccine 42(9) (2024) 2254-2259].

Vaccine·2026
Same journal

Innovative webinar-based training to support evidence-to-recommendation decision-making by national immunization technical advisory groups: multi-country experience with hexavalent vaccines.

Vaccine·2026
Same journal

Under-vaccination as a systems failure: A Monte Carlo simulation of the 2025 CDC/ACIP hepatitis B birth-dose policy shift and multi-level intervention packages, 2025-2035.

Vaccine·2026
See all related articles